Royalty Pharma
RPRX
HK$245.40
Share price
-6.52%
Change (1 day)
3.77%
Change (1 year)
Categories
P/S ratio for Royalty Pharma (RPRX)
P/S ratio as of March 2025 (TTM): 8.60
According to Royalty Pharma's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.88. At the end of 2024 the company had a P/S ratio of 6.65.
P/S ratio history for Royalty Pharma from 2020 to 2024
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2024 | 6.65 | -7.06% |
| 2023 | 7.15 | -8.2% |
| 2022 | 7.79 | 4.23% |
| 2021 | 7.48 | -18.32% |
| 2020 | 9.15 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 | 2.38 | -72.33% | 🇺🇸 USA |
 | 5.23 | -39.12% | 🇺🇸 USA |
 | 17.0 | 97.65% | 🇺🇸 USA |